Skip to content
Screener

Rogers Corporation ROG Cash & Equivalents

Cash & Equivalents at other companies

3M logo
3MMMM
$2.96B-20.4%
Celldex Therapeutics logo
Celldex TherapeuticsCLDX
$47.45M+106%
Biogen logo
BiogenBIIB
$1.29B-53.4%
Aurinia Pharmaceuticals logo
Aurinia PharmaceuticalsAUPH
$179.83M+239%
DuPont de Nemours, Inc. logo
DuPont de Nemours, Inc.DD
$752M-57.1%
Inhibrx Biosciences, Inc. logo
Inhibrx Biosciences, Inc.INBX
$161.66M-25.3%

Other financials

Income statement

See full
Revenue$216.8M+6.9%
Gross profit$70.4M+10.0%
Operating income$20.0M+130%
Net income$13.6M+118%
EPS (diluted)$0.76+119%

Balance sheet

See full
Total debt$28.5M-14.2%
Total equity$1.2B-0.2%
Total assets$1.4B-0.3%

Cash flow

See full
Operating cash flow$24.4M+78.1%
CapEx$6.1M-24.7%
Free cash flow$18.3M+227%

Valuation

See full
Market cap$2.39B+87.0%
Enterprise value$2.24B+93.9%
P/E89.5×
P/S2.9×+1.3×

Profitability

See full
Gross margin32.4%+0.2pp
Operating margin8.1%-6.7pp
Net margin3.2%+1.9pp
FCF margin9.9%+3.5pp

Returns & leverage

See full
Return on equity2.2%+1.3pp
Debt / equity0.0×
Current ratio+0.2×

Where this comes from

Reported directly by Rogers Corporation in its filing.

Tagged under the XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue.

The source filing: Rogers Corporation’s 10-Q, filed July 29, 2026.

Filed
Jul 28, 2026, 8:00 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0000084748-26-000048
Line itemJune 30, 2026December 31, 2025
Assets
Current assets
Cash and cash equivalents$181.4$197.0
Short-term investments30.0
Accounts receivable, net149.2130.6
Contract assets27.127.9
Inventories, net130.0125.0
Asbestos-related insurance recoverables, current portion4.74.7

Item 1. Condensed Consolidated Financial Statements (Unaudited):

FAQ

What is Rogers Corporation's cash & equivalents?
Rogers Corporation (ROG) reported cash & equivalents of $181.4M in Q2 2026.
How has Rogers Corporation's cash & equivalents changed year-over-year?
Rogers Corporation's cash & equivalents increased by 15.4% year-over-year, from $157.2M to $181.4M.
What is the long-term trend for Rogers Corporation's cash & equivalents?
Over 5 years (2020 to 2025), Rogers Corporation's cash & equivalents has grown at a 0.5% compound annual growth rate (CAGR), from $191.79M to $197M.
What does cash & equivalents mean?
Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.

Ask your AI about Rogers Corporation's cash & equivalents.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude